Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact
Arq. neuropsiquiatr; 74 (3), 2016
ABSTRACT Multiple sclerosis (MS) was always considered as a white matter inflammatory disease. Today, there is an important body of evidence that supports the hypothesis that gray matter involvement and the neurodegenerative mechanism are at least partially independent from inflammation. Gray matter atro...